CVVT

新聞稿   即時發佈  【中國香港— 2026年3月31日】 — 比幹生物有限公司（比幹生物）、InnoHK 病毒與疫苗研究中心（CVVT）、深圳華大智造科技股份有限公司（華大智造）以及臨床腫瘤學合作夥伴鄺麗雲教授今日宣布策略性合作，並成立 PDOHub™ HK ，即 亞洲首個整合式類器官精準醫學中心 。這項策略性合作結合前沿類器官技術、自動化系統及臨床專業知識，旨在加速精準醫學發展、輔助臨床決策，並推動腫瘤學及傳染病領域的轉化研究。 亞洲首個整合式 PDOHub™ HK 該策略性合作協議體現各方共同致力於建立及發展一個專注於患者來源類器官（PDO）技術的中心，以推進多個疾病領域的精準醫學、臨床決策及轉化研究。PDOHub™ HK（以下簡稱 PDOHub）將作為開發及擴展類器官應用技術的核心樞紐，連接前沿科學與臨床實踐。透過提供患者個性化的深度見解，該計劃賦能研究人員和醫療合作夥伴，加速在傳染病、腫瘤和其他新興健康挑戰領域的發現並完善治療策略，從而使PDOHub成為亞洲領先的類器官驅動型精準醫療中心。 近十年類器官科研為 PDOHub™ HK 奠定基礎...

PRESS RELEASE FOR IMMEDIATE RELEASE    HONG KONG, China, 31 March 2026 – BiomOrgan Limited (BiomOrgan), InnoHK Centre for Virology, Vaccinology, and Therapeutics (CVVT), MGI Tech Co., Ltd. (MGI), and clinical oncology partner Professor Dora Kwong today announced the strategic collaboration and the establishment of PDOHub™ HK, Asia’s first integrated Organoid-Based Precision Medicine Centre . This strategic collaboration harnesses cutting-edge organoid technology, automation, and clinical...

We are incredibly proud to announce that the InnoHK Centre for Virology, Vaccinology, and Therapeutics (InnoHK CVVT) has been awarded five medals at the 51st International Exhibition of Inventions Geneva for our advancements in biomedicine and biotechnology. From March 11th to 15th, CVVT made its mark on the global stage, sending five teams to the International Exhibition of Inventions Geneva 2026. They joined over 1,000 innovations from more than 40 countries, showcasing the depth of talent...